Release of growth factors and the effect of age, sex, and severity of injury after long bone fracture

Acta Orthopaedica

Volumn 84, Issue , 2013, Pages 65-70

  Pountos, Ippokratis ^a   Georgouli, Theodora ^a   Henshaw, Karen ^a   Bird, Howard ^a   Giannoudis, Peter V ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; INSULIN GROWTH FACTOR I; PLATELET DERIVED GROWTH FACTOR BB; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGE; AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMUR FRACTURE; HUMAN; INJURY SCALE; INJURY SEVERITY; MALE; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SEX; TIBIA FRACTURE;

ADULT; AGE FACTORS; AGED; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMORAL FRACTURES; FRACTURE HEALING; FRACTURES, BONE; HUMANS; INJURY SEVERITY SCORE; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PLATELET-DERIVED GROWTH FACTOR; SEX FACTORS; TIBIAL FRACTURES; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84873937809     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.3109/17453674.2013.765624     Document Type: Article

References (35)

1. Bab I, Gazit D, Muhlrad A, Shteyer A. Regenerating bone marrow produces a potent growth-promoting activity to osteogenic cells. Endocrinology 1988; 123 (1): 345-52.
2. Barnes G L, Kostenuik L C, Gerstenfeld L C, Einhorn T A. Growth factor regulation of fracture repair. J Bone Miner Res 1999; 14 (11): 1805-15.
3. Bauer D C, Rosen C, Cauley J, Cummings S R. Low serum IGF-1 but not IGFBP-3 predicts hip and spine fracture: The study of osteoporotic fracture. Bone 1998; 23 (6): 561-2.
4. Bostrom M P, Lane J M, Berberian W S, Missri A A, Tomin E, Weiland A, Doty S B, Glaser D, Rosen V M. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J Orthop Res 1995; 13 (3): 357-67.
5. Bouletreau P J, Warren S M, Spector J A, Steinbrech D S, Mehrara B J, Longaker M T. Factors in the fracture microenvironment induce primary osteoblast angiogenic cytokine production. Plast Reconstr Surg 2002; 110 (1): 139-48.
6. Chachques J C, Herreros J, Trainini J, Juffe A, Rendal E, Prosper F, Genovese J. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int J Cardiol (Suppl 1) 2004; 95: S29-33.
7. Dimitriou R, Tsiridis E, Giannoudis P V. Current concepts of molecular aspects of bone healing. Injury 2005; 36 (12): 1392-404.
8. Einhorn T A, Simon G, Devlin V J, Warman J, Sidhu S P, Vigorita V J. The osteogenic response to distant skeletal injury. Bone Joint Surg (Am) 1990; 72 (9): 1374-8.
9. Fiedler J, Roderer G, Gunther K P, Brenner R E. BMP-2, BMP-4, and PDGFbb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem 2002; 87 (3): 305-12.
10. Gazit D, Zilberman Y, Turgeman G, Zhou S, Kahn A. Recombinant TGFbeta1 stimulates bone marrow osteoprogenitor cell activity and bone matrix synthesis in osteopenic, old male mice. J Cell Biochem 1999; 73 (3): 379- 89.
11. Giannoudis P V, Pountos I, Morley J, Perry S, Tarkin H I, Pape H C. Growth factor release following femoral nailing. Bone 2008; 42 (4): 751-7
12. Giannoudis P V, Kanakaris N K, Dimitriou R, Gill I, Kolimarala V, Montgomery R J. The synergistic effect of autograft and BMP-7 in the treatment of atrophic nonunions. Clin Orthop 2009; (467) (12): 3239-48.
13. Homburger J A, Meiler S E. Anesthesia drugs, immunity, and long-term outcome. Curr Opin Anaesthesiol 2006; 19 (4): 423-8.
14. Johansson A G, Burman P, Westermark K, Ljunghall S. The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor I. J Intern Med 1992; 232 (5): 447-52.
15. Kanakaris N K, Mallina R, Calori G M, Kontakis G, Giannoudis P V. Use of bone morphogenetic proteins in arthrodesis: clinical results. Injury (Suppl 3) 2009; 40: S62-6.
16. Manolagas S C, Jilka R L. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995; 332 (5): 305-11.
17. Nicholson G, Hall G M. Effects of anaesthesia on the inflammatory response to injury. Curr Opin Anaesthesiol 2011; 24 (4): 370-4.
18. Pierce G F, Mustoe T A, Altrock B W, Deuel T F, Thomason A. Role of platelet- derived growth factor in wound healing. J Cell Biochem 1991; 45 (4): 319-26.
19. Pittenger M F, Mackay A M, Beck S C, Jaiswal R K, Douglas R, Mosca J D, Moorman M A, Simonetti D W, Craig S, Marshak D R. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284 (5411): 143-7.
20. Pountos I, Giannoudis P V. Biology of mesenchymal stem cells. Injury (Suppl 3) 2005; 36: S8-S12.
21. Pountos I, Jones E, Tzioupis C, McGonagle D, Giannoudis P V. Growing bone and cartilage. The role of mesenchymal stem cells. J Bone Joint Surg (Br) 2006; 88 (4): 421-6.
22. Pountos I, Corscadden D, Emery P, Giannoudis P V. Mesenchymal stem cell tissue engineering: techniques for isolation, expansion and application. Injury (Suppl 4) 2007; 38: S23-33.
23. Pountos I, Georgouli T, Giannoudis P V. The effect of autologous serum obtained after fracture on the proliferation and osteogenic differentiation of mesenchymal stem cells. Cell Mol Biol (Noisy-le-grand) 2008; 54 (1): 33-9.
24. Pountos I, Georgouli T, Henshaw K, Bird H, Jones E, Giannoudis P V. The effect of bone morphogenetic protein-2, bone morphogenetic protein-7, parathyroid hormone, and platelet-derived growth factor on the proliferation and osteogenic differentiation of mesenchymal stem cells derived from osteoporotic bone. J Orthop Trauma 2010a; 24 (9): 552-6.
25. Pountos I, Georgouli T, Kontakis G, Giannoudis P V. Efficacy of minimally invasive techniques for enhancement of fracture healing: evidence today. Int Orthop 2010b; 34 (1): 3-12.
26. Rosen C J, Donahue L R. Insulin-like growth factors and bone: the osteoporosis connection revisited. Proc Soc Exp Biol Med 1998; 219 (1) :1-7.
27. Schmidmaier G, Wildemann B, Gabelein T, Heeger J, Kandziora F, Haas N P, Raschke M. Synergistic effect of IGF-I and TGF-beta1 on fracture healing in rats: single versus combined application of IGF-I and TGF-beta1. Acta Orthop Scand 2003; 74 (5): 604-10.
28. Selvaggi T A, Walker R E, Fleisher T A. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virusinfected patients given syngeneic lymphocyte infusions. Blood 1997; 89 (3): 776-9.
29. Si X, Jin Y, Yang L, Tipoe G L, White F H. Expression of BMP-2 and TGFbeta 1 mRNA during healing of the rabbit mandible. Eur J Oral Sci 1997; 105 (4): 325-30.
30. Spees J L, Gregory C A, Singh H, Tucker H A, Peister A, Lynch P J, Hsu S C, Smith J, Prockop D J. Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol- Ther 2004; 9(5): 747-56.
31. Street J, Bao M, deGuzman L, Bunting S, Peale F V Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland J L, Daugherty A, van Bruggen N, Redmond H P, Carano R A, Filvaroff E H. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 2002; 99 (15): 9656-61.
32. Tuschong L, Soenen S L, Blaese R M, Candotti F, Muul L M. Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. Hum Gene Ther 2002; 13 (13): 1605-10.
33. Wildemann B, Schmidmaier G, Ordel S, Stange R, Haas N P, Raschke M. Cell proliferation and differentiation during fracture healing are influenced by locally applied IGF-I and TGF-beta1: comparison of two proliferation markers, PCNA and BrdU. J Biomed Mater Res B Appl Biomater 2003; 65 (1): 150-6.
34. Zelzer E, McLean W, Ng Y S, Fukai N, Reginato A M, Lovejoy S, D'Amore P A, Olsen B R. Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 2002; 129 (8): 1893-904.
35. Zimmermann G, Henle P, Kusswetter M, Moghaddam A, Wentzensen A, Richter W, Weiss S. TGF-beta1 as a marker of delayed fracture healing. Bone 2005; 36 (5): 779-85.